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Objectives. Cementogenesis seems to be significantly compromised during tissue inflammation. In dental practice, surgical
procedures are performed with the aim to regenerate periodontium including cementum. However, inflammation that occurs
during the initial healing phases after surgery may impair regeneration of this tissues. The aim of the present study was to assess
if surgical procedures designed to regenerate periodontium might affect levels of cementum protein-1 (CEMP-1) in periodontal
wound fluid during early phase of healing. Materials and Methods. In 36 patients, 18 intrabony periodontal defects were treated
with regenerative therapy (REG group) and 18 suprabony periodontal defects were treated with open flap debridement (OFD
group). In the experimental sites, gingival crevicular fluid was collected immediately before surgery, and periodontal wound
fluid was collected 4, 7, 14, and 21 days after surgery. CEMP-1 levels were detected by indirect enzyme-linked immunosorbent
assay technique. Results. At the analysis, it resulted that there was a significant average difference in CEMP-1 values between the
REG and OFD groups at baseline (p = 0 041), the CEMP-1-modeled average in the OFD group was lower by 0.45 ng/ml. There
was a significant trend in CEMP-1 over time, and this trend was different among the 2 groups: the REG group showed a
statistically significant rising CEMP-1 trend (0.18 ng/ml a week p = 0 012), while the OFD had a trend that was significantly
lower (-0.22 ng/ml a week compared to the REG group trend p = 0 023), the OFD group lost on average 0.05 ng/ml a week. In
REG sites, GCF protein levels resulted also related to clinical parameters. Conclusions. During the initial inflammatory phase of
periodontal healing, CEMP-1 levels decrease regardless of the surgical protocol applied. The surgical procedures used to
regenerate periodontal tissue are able to reverse this trend and to induce significant increase of CEMP-1 in periodontal wound
fluid after the first week postop.
1. Introduction
Gingival crevicular fluid (GCF) is a physiological serum tran-
sudate that flows through the junctional epithelium to gingi-
val sulcus and that can be collected at the gingival margin or
within the gingival crevice. This fluid is called periodontal
wound fluid (PWF) when it is derived from postsurgical heal-
ing sites. After periodontal surgical trauma, cell-signaling
protein molecules (e.g., growth factors, chemokines, or
cytokines) and products of cellular activity (enzymes and
adhesion molecules) are released in the wound-healing area.
Levels of cytokines, chemokines, and angiogenic biomarkers
within the gingival crevicular fluid and in periodontal wound
fluid have been studied in clinical trials to assess the ongoing
angiogenesis, connective tissue, and bone formation activities
during wound-healing phases (inflammation, granulation tis-
sue formation, and tissue neoformation/remodeling) [1, 2].
Morelli et al. [3] evaluated changes of angiogenic markers in
wound fluid after placement of a soft tissue autograft or of a
living cellular construct for treatment of mucogingival
defects. The authors observed that these procedures heal in
two different ways and that levels of the analyzed biomarkers
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also resulted different. Eren et al. [4] characterized the
wound-healing activity and inflammation of localized
gingival recession defects treated with coronally advanced
flap plus platelet-rich fibrin compared with coronally
advanced flap plus connective tissue graft, and they observed
that platelet-rich fibrin may promote early wound healing by
elevating the levels of tissue inhibitor of matrix metallopro-
teinases-1 and suppressing the levels of proinflammatory
and remodeling molecules (matrix metalloproteinase-8 and
IL-1b) in gingival crevicular fluid at 10 days after surgery.
Pellegrini et al. [5] assessed the levels of proteins related to
epithelium, connective tissue, and bone healing as possible
biological indicators of clinical outcome at 6months after sur-
gery. Comprehension of physiology of cementum and related
molecules is important for the development of potential new
therapies in periodontal regeneration. However, clinical
studies evaluating specific markers for cementum activity are
lacking. Cementum protein-1 (CEMP-1) is a tissue-specific
protein for cementum. This protein is only expressed by
cementoblasts, their progenitors, and by periodontal
ligament-derived cells [6, 7]. CEMP-1 has been detected
lining the cementum surface, in the perivascular area and
within the periodontal ligament throughout the root surface
[6]. One in vitro study observed that CEMP-1 stimulates
migration and proliferation of periodontal ligament cells
and promotes cell differentiation, maturation, and deposition
of mineralized extracellular matrix resembling cementum
[7]. It also reduces the level of osteoblastic markers and
increases the amount of cementoblastic markers. Further-
more, overexpression of CEMP-1 was found to slightly
increase cementogenesis and differentiation of cementoblasts
[7]. The levels of CEMP-1 reduce significantly after stimula-
tion of cementoblasts with IL-1β, and cementogenesis may
be significantly compromised during tissue inflammation
[8]. In dental practice, surgical procedures are performed
with the aim to regenerate periodontium including cemen-
tum, ligament, and alveolar bone. However, inflammation
that occurs during the initial healing phases after surgery
may impair this tissue regenerative activity.
The aim of the present study was to assess if surgical
procedures designed to regenerate periodontium might
affect levels of CEMP-1 in periodontal wound fluid during
initial healing.
2. Materials and Methods
This is a prospective clinical trial. The study has been
approved by the ethical committee of Università degli Studi
di Milano (Italy) (18.10.11, number 30/11). All procedures
performed in the studies involving human participants were
in accordance with the ethical standards of the institutional
and/or national research committee and with the 1964
Helsinki Declaration and its later amendments or compara-
ble ethical standards.
2.1. Study Population. A total of 36 volunteers were enrolled:
18 patients that had an intrabony periodontal defect requir-
ing regenerative therapy (REG group) and 18 patients that
had a horizontal periodontal defect (without intrabony
components) requiring open flap debridement (OFD group).
Enrolled patients presented the following inclusion criteria:
(i) age range: 25-80 years old
(ii) nonsmoking (former smokers were included if they
had not smoked within 6 months of the study
initiation)
(iii) suffering from periodontitis at stage 3 grade B [9]
and completed the initial periodontal therapy from
at least 3 months
(iv) defect anatomy OFD group: presence of at least
one tooth with probing pocket depth (>5mm)
and clinical attachment level with an intrabony
defect ≤ 3mm
(v) defect anatomy REG group: presence of at least one
tooth with probing pocket depth (>5mm) and clin-
ical attachment level of ≥5mm associated with an
intrabony defect of >3mm
(vi) good oral hygiene: full mouth plaque and bleeding
scores ≤ 20% at the beginning of the study
(baseline)
(vii) experimental teeth had to be vital or properly
treated with root canal therapy
(viii) subgingival margins, open margins, overhanging
margins, and inadequate restorations had to be
absent in the experimental site
The following exclusion criteria were applied:
(i) patients with clinically significant or unstable
organic diseases, immune-compromised, taking ste-
roid medications, chronically treated (i.e., two weeks
or more) with any medication known to affect
periodontal status (i.e., antibiotics or nonsteroidal
anti-inflammatory drugs), and taking antibiotics
within 90 days of baseline
(ii) patients displaying compromised healing potential
such as those affected by connective tissue disorders
or bone metabolic diseases; patients with conditions
requiring antibiotic prophylaxis
(iii) pregnant or lactating women, or women who were
of childbearing potential and not using birth control
or abstinence
(iv) current smokers or former smokers who had
smoked in the previous 6 months
(v) patients affected by active infectious diseases
2.2. Study Procedures. The study timeline is reported in
Figure 1. After verification of the inclusion/exclusion criteria
and sign of the informed consent, each patient was enrolled
into the study. Gingival crevicular fluid was harvested
and clinical measurements and radiographs were taken
(baseline). Before the surgical appointment, all patients
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underwent professional oral hygiene procedure and instruc-
tions were given to eliminate any infective complications.
Each patient’s compliance to the experimental protocol was
also confirmed.
In both groups (open flap debridement and regenerative
therapy), local anesthesia with mepivacaine 2% 1 : 100.000
epinephrine was administered. In all the sites (OFD and
REG), full-thickness flap was incised and elevated.
In the 18 REG sites, the simplified papilla preservation
technique was adopted whenever the width of the interdental
space was 2mm or narrower, while the modified papilla pres-
ervation technique was applied when the interdental sites
were wider than 2mm [10, 11]. The intrasulcular interdental
incision (SPPF or MPPT) was extended to the buccal and
lingual aspects of the mesial and distal teeth adjacent to the
defect. After flap elevation, the granulation tissue was
removed, and the intrabony defects were cleaned by hand
instrumentation, ultrasonic scalers, and the root planning
was done. Vertical releasing incisions were performed
when flap reflection caused tension at the extremities of
the flap(s). REG defects were covered with a nonresorbable
titanium-reinforced completely inert membrane (dense
polytetrafluoroethylene) (Cytoplast®, Osteogenics Biomedi-
cal, Lubbock, Texas, USA) alone with no bone substitutes
and closed with a single modified internal mattress suture
(polytetrafluoroethylene 6/0); thus, a tension-free primary
closure of the papilla was obtained (Figure 2).
In the OFD sites, modified Widman Flap was performed
[12]. After flap elevation, the granulation tissue was removed,
and the horizontal defects were cleaned by hand instrumen-
tation, ultrasonic scalers, and the roots were planned. The
OFD sites were closed with a single external mattress suture
(polytetrafluoroethylene 5/0) (Figure 3).
Postoperative pain and edema were controlled with
ibuprofen. Patients received 600mg at the beginning of the
surgical procedure and were instructed to take another tablet
GCFc
CA
Surgery
BL 4 d
PWFc
PSA
PWFc
PSA
7 d 14 d 21 d 6 m
CAPWFc
PSA
PWFc
PSA
Enrollment
Signed
informed
consent
6 w
MR
Figure 1: Timeline of the study. GCFc: gingival crevicular fluid collection; CA: clinical assessments (probing pocket depth, clinical
attachment level, full mouth plaque and bleeding, photographs, X-ray); PWFc: periodontal wound fluid collection; PSA: postsurgical
clinical assessments of healing; BL: baseline; d: days; MR: membrane removal.
(a) (b)
(c) (d)
Figure 2: In the sites with intrabony periodontal component, after flap elevation, the granulation tissue was removed and roots were planned
(a). The defect was covered with nonresorbable titanium-reinforced completely inert membrane (dense polytetrafluoroethylene) alone
with no bone substitutes (b) and closed with a single-modified internal mattress suture (c). The membrane was removed 6 weeks
after surgery (d).
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6 hours later. Subsequent doses were taken only if necessary
to control pain. Patients with ulcers, gastritis, and other con-
traindications to nonsteroidal anti-inflammatory drugs
received 500mg acetaminophen. All patients were instructed
to intermittently apply an ice bag on the operated area (20
minutes per hour for 24 hours). All patients were instructed
to discontinue tooth brushing and avoid trauma at the surgi-
cal site for a period of time ranging between 3 and 4 weeks. A
60-second rinse with 0.12% chlorhexidine digluconate was
prescribed 3 times/day for the first 3 to 4 weeks.
At 4, 7, 14, and 21 days after surgery, periodontal wound
fluid was collected by a blind operator (EC). Clinical mea-
surements were taken 6 months after surgery.
2.3. Gingival Crevicular Fluid or Periodontal Wound Fluid
Harvesting and Analysis. In all the patients, gingival cre-
vicular fluid or periodontal wound fluid was collected
from the study site at baseline, and 4, 7, 14, and 21 days
after surgery (Figure 1) as previously reported [13]. Prior
to crevicular fluid collection, supragingival plaque biofilm
in the area around each sample was removed and the
site was air-dried. Two methylcellulose paper strips
(Periopaper®, ProFlow Inc., Amityville, NY) were gently
inserted in the gingival sulcus or periodontal pocket for
1-2mm. The fluid sample was then collected for 30 seconds,
and the strips were placed into the Eppendorf tubes. The
samples of gingival crevicular fluid and periodontal wound
fluid were subsequently kept on dry ice and stored at -20°C
until analysis.
Prior to biomarker analysis, gingival crevicular fluid and
periodontal wound fluid were thawed at room temperature,
and proteins were eluted with 100μL of 1× phosphate buff-
ered saline solution and Protease Inhibitor PMSF (Thermo
Fisher Scientific, Italy). To retrieve the crevicular fluid sam-
ple, the paper strips were centrifuged at 15 000×g for 5min
for 4 times, and the total volume of 100μL was obtained.
The indirect enzyme-linked immunosorbent assay technique
was used to detect and quantify levels of CEMP-1 protein
(ng/ml) in the crevicular/wound fluid using the MBS702364
kit (MyBioSource) according to manufacturer’s instruc-
tion. The indirect enzyme-linked immunosorbent assay
test was performed measuring the absorbance at 450 nm by
means of a spectrophotometer plate reader (Wallac Victor
II plate reader).
(a) (b)
(c) (d)
Figure 3: Modified Widman Flap was performed in sites with suprabony periodontal defects (a). After flap elevation, the granulation tissue
was removed and roots were planned (b). Sites were closed with single external mattress suture (c). Sutures were removed 1 week after
surgery (d).
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2.4. Clinical and Radiographical Analysis. The following
clinical measurements were taken at baseline and 6 months
after surgery:
(i) full mouth plaque and bleeding score at the four sites
for all teeth
(ii) probing pocket depth, recession, and clinical attach-
ment level (calculated as the sum of probing pocket
depth and recession) were assessed at six sites of each
tooth treated
Reduction of probing pocket depth and gain of clinical
attachment level were calculated, respectively, as the differ-
ence between probing pocket depth or clinical attachment
level at baseline and probing pocket depth or clinical attach-
ment level at 6 months.
All measurements were taken with a UNC periodontal
probe (Hu-Friedy Manufacturing Company Inc., Chicago,
IL, USA).
Intraoral radiographs of the defect were taken using
Rinn’s attachment and a long cone parallel technique at
baseline and 6 months after periodontal surgery.
Intraoral photographs of the experimental sites were
taken before surgery, after defect debridement, after flap
closure, at weeks 1, 2, and 3, and at 6 months.
2.5. Statistical Analysis. Each patient represented a statistical
unit, and only one defect was treated for each volunteer. In
both groups, mean and standard deviation were calculated
for probing pocket depth (mm) and clinical attachment level
(mm) at baseline and at 6 months postop and for levels of
CEMP-1 (ng/ml) at baseline and 4, 7, 14, and 21 days
after surgery.
Preliminary analysis was carried out at baseline measur-
ing the difference in mean CEMP-1 (ng/ml) levels between
the REG and OFD groups with a t-test. As a first evaluation,
t-tests of average differences between CEMP-1 at baseline
and treatment day 21st were carried out between the groups
(i.e., REG and OFD); furthermore, t-tests for paired data
were applied to both the REG and OFD groups between
CEMP-1 levels at baseline and day 21st. These evaluations
were only carried out between measurements at baseline
and at day 21st to avoid pseudoreplication and multiple
testing issues.
To properly characterize the data, a linear mixed model
was used, in order to account for repeated measures on
patients over time [14]. The study treatment group (REG vs
OFD) and time (observation week) and their interaction to
capture nonparallel growth trends were included as fixed
effects; patients were considered as random effects in partic-
ular with respect to time (days). Finally, since the same
patients were measured over time, a first order autocorrela-
tion structure was used. The nlme library from the R-project
statistical suit was used to fit the linear mixed model. A level
of significance of 5% (p < 0 05) was considered.
3. Results
A total of 36 nonsmoker patients, 18 for each group, were
enrolled. One patient in the OFD group discontinued early,
and analysis was performed on 18 patients of the REG group
(12 females and 6 males; mean age, 55 9 ± 9 2) and on 17
patients of the OFD group (10 females and 7 males; mean
age, 58 3 ± 11 6). Demographic and clinical data of patients
are reported in Table 1, and no significant differences were
found between the groups. Uneventful wound healing
occurred in all the operated sites. In the sites treated with
regenerative procedure, no membrane exposure occurred,
and all membranes were removed at 5-6 weeks after surgery.
3.1. CEMP-1 Levels. Levels of CEMP-1 in gingival crevicular
fluid at baseline and periodontal wound fluid at 4 days and 1,
2, and 3 weeks postop in the sites treated with regenerative
approach and open flap debridement are reported in
Figure 4.
At baseline, CEMP-1 showed significantly different
levels between the REG and OFD groups (OFD mean
0.80, REG mean 1.39; t-test, p = 0 035); variability was also
different between the two groups (OFD variance 0.46, REG
variance 0.78).
Due to these differences at baseline, direct comparisons
of CEMP-1 at later time points would have been inappropri-
ate, to make up for this bias a t-test was performed on the
difference from baseline CEMP-1 values between the groups
Table 1: Data on study population.
Parameter Mean ± sd in the REG group Mean ± sd in the OFD group P value between
the groups
Age (years) 55 9 ± 9 2 58 3 ± 11 6 ns
Full mouth plaque score (%) 5 7 ± 2 8 6 5 ± 2 9 ns
Full mouth bleeding score (%) 3 9 ± 1 8 4 6 ± 2 9 ns
Probing pocket depth at experimental sites (mm)
8 ± 1 8 (BL) 5 3 ± 0 6 (BL)
ns4 1 ± 1 (6m) 2 9 ± 0 7 (6m)
Clinical attachment level at experimental sites (mm)
9 7 ± 2 9 (BL) 6 2 ± 1 5 (BL)
ns5 4 ± 2 1 (6m) 4 3 ± 1 1 (6m)
Experimental sites that bleed on probing at baseline (%)
61.1% (BL) 44.4% (BL)
ns
5.5% (6m) 0 (6m)
REG: sites that underwent to regenerative therapy; OFD: sites treated with open flap debridement; NS: not statistically significant; BL: baseline; 6m: 6 months.
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at day 21st. This test was also significant (p = 0 031), with the
REG group recording a 0.64 ng/ml rise in CEMP-1, and the
OFD a 0.32 ng/ml fall between baseline and day 21st. Finally,
to determine whether the change from baseline within each
group was significant, pairwise t-tests were performed on
the REG and OFD groups between baseline and day 21st
individually. These tests indicated that the change in the
REG group, even though larger (+0.64 ng/ml) was not
statistically significant (p = 0 12), while the smaller change
in the OFD group (-0.32 ng/ml) was barely significant
(p = 0 049), this result underscores the difference in variance
between the 2 groups.
Figure 5 represents the data by timepoint (baseline and
21 days after intervention) and by the treatment group using
boxplots. On inspection, strong differences in CEMP-1 levels
emerged, both in value and in variability. The REG group
CEMP-1 average and median values are higher than the
OFD group ones at all time points, but also noticeably more
dispersed as shown in the descriptive and preliminary analy-
sis above. The model confirmed what can be seen in the data
from inspection i.e., (1) that there was a significant average
difference in CEMP-1 values between the REG and OFD
groups at baseline (p = 0 041), the CEMP-1 modeled average
in the OFD group was lower by 0.45 ng/ml, (2) there was a
significant trend in CEMP-1 over time and this trend was dif-
ferent among the 2 groups: the REG group showed a statisti-
cally significant rising CEMP-1 trend (0.18 ng/ml a week
p = 0 012), while the OFD had a trend that was significantly
lower (-0.22 ng/ml a week compared to the REG group trend
p = 0 023), the OFD group lost on average 0.05 ng/ml a week.
3.2. Analysis of Correlation. A significant correlation
(Spearman correlation) was found in the REG sites among
(i) CEMP-1 levels at 3 weeks and probing pocket depth
reduction ((p = 0 041, r = 0 486), (p = 0 801 in the
OFD sites))
(ii) differential CEMP-1 levels between 3w and baseline
and probing pocket depth reduction ((p = 0 041,
r = 0 485), (p = 0 128 in the OFD sites))
(iii) differential CEMP-1 levels between 3w and baseline
and probing pocket depth baseline ((p = 0 027,
r = 0 519), (p = 0 102 in the OFD sites))
4. Discussion
During the early (inflammatory) phase of healing that occurs
after periodontal surgery, the levels of inflammatory markers
peak, thus negatively affecting periodontal as well as cemen-
tum neoformation and shifting healing toward a more
reparative than regenerative process [8, 15]. In periodontal
regenerative surgery, accuracies are put in place to achieve
regeneration of periodontium (alveolar bone and cementum
with inserted perpendicularly oriented periodontal ligament
fibers) and the trend of regenerative markers may be affected
accordingly. In the present study, we evaluated if the levels of
CEMP-1 in periodontal wound fluid change during initial
healing after surgical procedure designed to regenerate peri-
odontium. From data, it resulted a different trend of PWF
CEMP-1 amount after periodontal regenerative surgery
compared to periodontal surgery alone. In the REG sites,
after initial decrease, the protein level increased significantly,
while in the OFD sites remained at levels significantly lower
than baseline. The decreased amount of this protein observed
in all the treated sites after surgery may have resulted from
the activation of inflammatory cells, in the initial healing
phase [8]. Initial defect degranulation and subsequent
removal of cells that synthesize CEMP-1 may also have
BL 4 d 7 d 14 d 21 d
ng
/m
l
CEMP-1
REG
OFD
2.5
2
1.5
1
0.5
0
Figure 4: LevelsofCEMP-1 ingingival crevicularfluid (atbaseline,0)
and periodontal wound fluid at 4, 7, 14, and 21 days (d), postop
in sites treated with regenerative approach (REG) and open flap
debridement (OFD).
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0
Follow-up day
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Whole period comparison
by treatment and follow-up day 
Baseline After treatment
REG group regression line
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Figure 5: Plot representing distribution of CEMP-1 in ng/ml by
treatment and week (baseline is day 0, while days 4 to 21 are after
treatment) using box plots. The REG group is white, OFD is grey,
the thick black line is the median, the box contains the 1st to the
3rd quartile, and the whiskers are the lowest and highest values
within 1.5 times the interquartile range from the box, other values
are represented as outliers. The regression lines from the linear
mixed model are also plotted (REG, line; OFD, dashed line).
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delayed the production of proregenerative proteins as well as
CEMP-1. In the OFD sites, the sustention of low levels of the
analyzed protein may indicate the ongoing periodontal tissue
repair with limited formation of new cementum/mineralized
tissue. After OFD, the recruitment and activation of cells may
mainly be devoted to epithelium and connective tissue heal-
ing as supported by increased amounts of fibroblast growth
factor-2 and transforming growth factor-β [1]. On the con-
trary, in the REG sites, the regenerative procedure seems to
invert this tendency increasing the CEMP-1 secretion by
cementoblasts; the mineralization activity seems to resume
after the initial flexion, thus suggesting the beginning of the
cementum regeneration with insertion of periodontal liga-
ment fibers. These data on different amounts of protein for
tissue neoformation confirm those of previous study. A dif-
ferent trend of local levels of matrix metalloproteinase-1
and bone morphogenetic protein-7 during early wound heal-
ing was found between periodontal surgery associated with
regenerative procedure and periodontal surgery alone. Fur-
thermore, this data was found to be related with the clinical
outcome of periodontal regenerative surgery, while sites that
underwent open flap debridement showed no such associa-
tion, thus suggesting that the connective tissue neoformation
and remodelling was ongoing at the site treated with regener-
ative therapy [5].
CEMP-1 has been analyzed in the present study as
a tissue-specific protein for cementum. This protein is
expressed by cementoblastoma-derived cells and periodontal
ligament cells and is localized throughout the cementum [6].
CEMP-1 seems to play a role in the early phases of mineral-
ization by promoting the formation of apatite crystals [6].
Within the periodontal ligament, this protein stimulates the
recruitment, proliferation, and maturation of mesenchymal
stem cells promoting their mineralization activity [16]. Data
on class II furcation defects of monkeys treated with
Matrigel® matrix alone or associated with human transform-
ing growth factor-β3 demonstrated that this growth factor
induces cementogenesis by upregulation of CEMP-1 and that
CEMP-1 is an indicator of cementogenesis [17].
The correlation analysis has shown that the increase of
CEMP-1 from baseline in the REG sites is moderately but
significantly related to PD reduction at 6 months. It can be
speculated that the short-term clinical outcome of periodon-
tal regenerative therapy may be predicted by early molecular
analysis of wound fluid. The sites with intrabony defects
treated with the regenerative approach showed significantly
higher levels of CEMP-1 than OFD sites both at baseline
and at all postop appointments, and the probing pocket
depth at baseline was related to the increase of CEMP-1 from
baseline to 3 weeks. Periodontal defects with a vertical bone
component have higher physiological remodeling activity
and innate regenerative potential than those with suprabony
component, and this may induce higher basal levels of
CEMP-1. For ethical reason, it was not possible to apply the
same surgical protocol to infrabony and suprabony defects.
The two interventions selected for this trial are different in
their nature, surgical protocol, and expected periodontal
healing events (regeneration vs. repair). In the sites where
the primary goal of intervention was tissue regeneration, it
may be expected that the blood clot stabilized under the
barrier membrane is progressively replaced by a new bone,
periodontal ligament, and cementum, as demonstrated histo-
logically in humans [18]. Otherwise, in the sites treated with
OFD where the primary goal was the pocket reduction
without tissue regeneration, no relevant cementogenesis or
osteogenesis is expected, and human histological studies
reported the formation of long junctional epithelium with
parallel-oriented collagen fibers [19, 20]. On the base of these
different healing profiles, the postop higher levels of CEMP-1
found in the REG sites than those in the OFD sites may
reflect the stronger cementogenesis and tissue mineralization
that occur in infrabony defects after regenerative procedure.
Ethical limits of harvesting periodontal tissue after regen-
eration in patients make the research of alternative noninva-
sive methods to assess biological events that occur during
healing necessary. In clinical practice, evaluation of cemento-
genesis by analysis of wound fluid may be useful to predict
the success of periodontal regeneration as well as to support
the development of further regenerative approaches. To our
knowledge, the present study is the first to define the possible
use of CEMP-1 as an early predictor of clinical outcome and
as a marker for cementogenesis, by confirming its presence in
gingival crevicular fluid/periodontal wound fluid of patients
and finding increased levels of this protein mostly in the sites
where regeneration of periodontal complex was expected.
Suprabony defects were chosen for comparison since
their different healing models supposedly induce a limited
CEMP-1 production thus highlighting the role of this protein
during healing. As the last point, it is necessary to identify the
reference level over which periodontal regenerative therapy
can be defined as successful. This reference level may be
hardly deductible, due to the high variability in CEMP-1
levels found especially in the REG group. This data that
may reflect the interindividual variability in regenerative
potential that normally exists between patients, as well as
the intraoperator variability for surgical performances. For
these reasons, further studies with increased number of sam-
ples and histological confirmation in humans are needed.
The application of this protein as an agent promoting
cementum regeneration would also be interesting. The effects
of bioresorbable scaffold loaded with rhCEMP-1 on the
attachment, proliferation, and osteogenic and cementogenic
differentiations of human periodontal ligament cells have
been investigated histologically in a critical size defect on
rodent, and the potential of generating cementum-like tissue
in vitro and in vivo has been demonstrated [21].
5. Conclusions
Data from this study supports that, after surgery, during the
initial inflammatory phase of periodontal healing, CEMP-1
levels decrease regardless of the surgical protocol applied.
The surgical procedures used to regenerate periodontal tissue
are able to reverse this trend and to induce significant
increase of CEMP-1 in periodontal wound fluid after the first
week postop.
Limited to gingival crevicular fluid/periodontal wound
fluid, CEMP-1 could be a marker for possible ongoing
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cementogenesis during the first 21 days of healing. It
would be interesting to design further clinical and histo-
logical studies evaluating levels of this protein in tissue
and in crevicular fluid of healthy sites as well as after
different nonsurgical/surgical procedures with the purpose
to define a reference value that may discriminate between
healing patterns.
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